Research in her lab is directed towards understanding the basis for sensitivity and resistance to cancer therapeutics and optimizing their use. She has published on this topic for the past 15 years. Several of her recent publications have described the mechanism of action of epigenetically targeted agents such as histone deacetylase inhibitors, either as single agents or in combination with other therapies. She has authored over 50 original research papers, invited reviews and book chapters.